Related Experiment Video
Updated: Apr 21, 2026

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
Published on: January 5, 2024
Cerebral venous thrombosis in inflammatory bowel disease
Ersilia M DeFilippis1, Elaine Barfield, Dana Leifer
1Department of Gastroenterology and Hepatology, Weill Cornell Medical College/New York Presbyterian Hospital, New York, NY, USA.
Insights
Cerebral venous thrombosis (CVT) is a rare complication of inflammatory bowel disease (IBD). Early recognition of neurological symptoms during IBD flares is crucial for timely anticoagulation and improved outcomes.
Area of Science:
- Neurology
- Gastroenterology
- Vascular Medicine
Background:
- Inflammatory bowel disease (IBD) is associated with various extraintestinal manifestations.
- Cerebral venous thrombosis (CVT) is a rare but serious complication that can occur in IBD patients.
- Prompt diagnosis and management of CVT are essential for patient outcomes.
Observation:
- A case series of six IBD patients presenting with symptoms suggestive of CVT, including headache.
- Imaging confirmed cerebral venous thrombosis in all six patients.
- Four patients had ulcerative colitis, and two had Crohn's disease.
Findings:
- All six patients received therapeutic anticoagulation for CVT.
- Two deaths occurred: one due to coma and neurological decline, the other due to bowel perforation weeks after CVT recovery.
- Neurological symptoms in IBD patients, especially during flares, warrant high suspicion for CVT.
Implications:
- This case series highlights the importance of early neurological assessment in IBD patients experiencing flares.
- Timely initiation of anticoagulation therapy can potentially improve neurological outcomes in CVT patients with IBD.
- Increased awareness among clinicians is needed to reduce morbidity and mortality associated with CVT in IBD.
Abstract:
Cerebral venous thrombosis (CVT) is a rare but devastating complication of inflammatory bowel disease (IBD). Here we describe six IBD patients with cerebral venous thrombosis. The patients presented with hours to days of headache and were found to have venous thrombosis on imaging. Four of the six patients had ulcerative colitis and two had Crohn's disease. All six patients were treated with therapeutic anticoagulation. There were two deaths; one patient became comatose and died despite anticoagulation while the other recovered well from the sinus thrombosis but died after a bowel perforation 3 weeks later. This case series demonstrates the critical need for early recognition of neurological symptoms in patients with IBD during disease flares. It is important to recognize the clinical signs in order to start anticoagulation expeditiously and improve neurological outcomes.
Related Concept Videos
Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...

